跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ICATIBANTO GP-PHARM 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ICATIBANTO GP-PHARM 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Approved
STANDARD
ICATIBANTO GP-PHARM 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Gp Pharm S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 3, 2022
Approval ID
ae446f30c4c8a912
Company
Gp Pharm S.A.
Type
Standard
Approval Details
Approval Id
ae446f30c4c8a912
Drug Cima Aemps Name
ICATIBANTO GP-PHARM 30 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA EFG
Register Number
86600
Holder Company Name
Gp Pharm S.A.
Marketing Company Name
Gp Pharm S.A.
Authorization Date
2022-03-03
Dosage Form
SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA
Dose
30 mg
Route Of Administration
VÍA SUBCUTÁNEA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Gp Pharm S.A.
Active Ingredients
ICATIBANTO
30 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 3, 2022
Approval ID
ae446f30c4c8a912
Type
Standard
Back to CIMA-AEMPS Approvals